Treventis
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
60 Leonard Ave, Toronto, Ontario, M5T 0S...Phone Number
(416) 603-5800Website
www.treventis.comRevenue
<$5 MillionIndustry
About Treventis
Treventis Corporation is a Canadian biotech start-up focused on treating and preventing protein misfolding diseases through its proprietary Common Conformational Morphology (CCM) technology. The company utilizes a patented discovery engine to identify druggable active sites in misfolded protein targets, with a lead program in partnership with Takeda aimed at developing anti-misfolding small molecules for Alzheimer's disease. Treventis also has ongoing efforts funded by the U.S. Department of Defense in oncology and other neurodegenerative diseases, showcasing the versatility of its technology platform. Their therapeutic areas include Alzheimer's disease, ALS, Parkinson's disease, and cancer.Explore more
Treventis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Treventis
Compare insights from companies similar to Treventis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Treventis Tech Stack
A closer look at the technologies used by Treventis
See more technologies
Top Business Services Companies
Frequently Asked Questions Regarding Treventis
Sign Up For FreeTo access detailed company insights
Treventis Corporation is a Canadian biotech start-up focused on treating and preventing protein misfolding diseases through its proprietary Common Conformational Morphology (CCM) technology. The company utilizes a patented discovery engine to identify druggable active sites in misfolded protein targets, with a lead program in partnership with Taked... Read More
